The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers
Open accessAbstract
Historically, multiple sclerosis (MS) has been viewed as being primarily driven by T cells. However, the effective use of anti-CD20 treatment now also reveals an important role for B cells in MS patients. The results from this treatment put forward T-cell activation rather than antibody production by B cells as a driving force behind MS. The main question of how their interaction provokes both B and T cells to infiltrate the CNS and cause local pathology remains to be answered. In this review, we highlight key pathogenic events involving B and T cells that most likely contribute to the pathogenesis of MS. These include (1) peripheral escape of B cells from T cell-mediated control, (2) interaction of pathogenic B and T cells in secondary lymph nodes, and (3) reactivation of B and T cells accumulating in the CNS. We will focus on the functional programs of CNS-infiltrating lymphocyte subsets in MS patients and discuss how these are defined by mechanisms such as antigen presentation, co-stimulation and cytokine production in the periphery. Furthermore, the potential impact of genetic variants and viral triggers on candidate subsets will be debated in the context of MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment
Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., & Glimcher, L. H. (2000) · Cell · doi:10.1016/s0092-8674(00)80702-3 · Cited by 3,589
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,386
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Zhou, L., Ivanov, I. I., Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D. E., Leonard, W. J., & Littman, D. R. (2007) · Nature Immunology · doi:10.1038/ni1488 · Cited by 2,141
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Hauser, S. L., Bar-Or, A., Comi, G., Giovannoni, G., Hartung, H.-P., Hemmer, B., Lublin, F., Montalban, X., Rammohan, K. W., Selmaj, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1601277 · Cited by 2,021
Genetic and epigenetic fine mapping of causal autoimmune disease variants
Farh, K. K.-H., Marson, A., Zhu, J., Kleinewietfeld, M., Housley, W. J., Beik, S., Shoresh, N., Whitton, H., Ryan, R. J. H., Shishkin, A. A., et al. (2015) · Nature · doi:10.1038/nature13835 · Cited by 1,956
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium, Patsopoulos, N. A., Baranzini, S. E., Santaniello, A., Shoostari, P., Cotsapas, C., Wong, G., Beecham, A. H., James, T., Replogle, J., et al. (2019) · Science · doi:10.1126/science.aav7188 · Cited by 1,818
Elices, M. J., Osborn, L., Takada, Y., Crouse, C., Luhowskyj, S., Hemler, M. E., & Lobb, R. R. (1990) · Cell · doi:10.1016/0092-8674(90)90661-w · Cited by 1,808
IL‐6: Regulator of Treg/Th17 balance
Kimura, A., & Kishimoto, T. (2010) · European Journal of Immunology · doi:10.1002/eji.201040391 · Cited by 1,595
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Magliozzi, R., Howell, O., Vora, A., Serafini, B., Nicholas, R., Puopolo, M., Reynolds, R., & Aloisi, F. (2006) · Brain · doi:10.1093/brain/awm038 · Cited by 1,443
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., & Aloisi, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00049.x · Cited by 1,208
Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1716 · Cited by 1,206
Microglial priming in neurodegenerative disease
Perry, V. H., & Holmes, C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.38 · Cited by 1,127
El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.-X., Dittel, B. N., & Rostami, A. (2011) · Nature Immunology · doi:10.1038/ni.2031 · Cited by 1,071 · cited 1×
“Such subsets are characterized by master transcription factors T-bet and RORγt (73, 74), of which the latter is involved in the coexpression of IL-17 and GM-CSF in mice but not in humans (75, 76).”
BackgroundPersistence of the Epstein–Barr Virus and the Origins of Associated Lymphomas
Thorley-Lawson, D. A., & Gross, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032015 · Cited by 1,054
Three or more routes for leukocyte migration into the central nervous system
Ransohoff, R. M., Kivisäkk, P., & Kidd, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1130 · Cited by 1,052
Expanding roles for CD4+ T cells in immunity to viruses
Swain, S. L., McKinstry, K. K., & Strutt, T. M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3152 · Cited by 956
Raychaudhuri, S., Sandor, C., Stahl, E. A., Freudenberg, J., Lee, H.-S., Jia, X., Alfredsson, L., Padyukov, L., Klareskog, L., Worthington, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.1076 · Cited by 946
Interleukin-10 determines viral clearance or persistence in vivo
Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., & Oldstone, M. B. A. (2006) · Nature Medicine · doi:10.1038/nm1492 · Cited by 923
The impact of the extracellular matrix on inflammation
Sorokin, L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2852 · Cited by 912
Identification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 892
Teng, M. W. L., Bowman, E. P., McElwee, J. J., Smyth, M. J., Casanova, J.-L., Cooper, A. M., & Cua, D. J. (2015) · Nature Medicine · doi:10.1038/nm.3895 · Cited by 873
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Howell, O. W., Reeves, C. A., Nicholas, R., Carassiti, D., Radotra, B., Gentleman, S. M., Serafini, B., Aloisi, F., Roncaroli, F., Magliozzi, R., et al. (2011) · Brain · doi:10.1093/brain/awr182 · Cited by 858
The Glymphatic System in Central Nervous System Health and Disease: Past, Present, and Future
Plog, B. A., & Nedergaard, M. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-051217-111018 · Cited by 780
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
Serafini, B., Rosicarelli, B., Franciotta, D., Magliozzi, R., Reynolds, R., Cinque, P., Andreoni, L., Trivedi, P., Salvetti, M., Faggioni, A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071030 · Cited by 766
Kurosaki, T., Kometani, K., & Ise, W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3802 · Cited by 691
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
Barr, T. A., Shen, P., Brown, S., Lampropoulou, V., Roch, T., Lawrie, S., Fan, B., O’Connor, R. A., Anderton, S. M., Bar-Or, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111675 · Cited by 649
Caldwell, R. G., Wilson, J. B., Anderson, S. J., & Longnecker, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80623-8 · Cited by 597
A functional and structural basis for TCR cross-reactivity in multiple sclerosis
Lang, H. L. E., Jacobsen, H., Ikemizu, S., Andersson, C., Harlos, K., Madsen, L., Hjorth, P., Sondergaard, L., Svejgaard, A., Wucherpfennig, K., et al. (2002) · Nature Immunology · doi:10.1038/ni835 · Cited by 591
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Neurath, M. F., & Finotto, S. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.02.003 · Cited by 576
Single-cell genomics unveils critical regulators of Th17 cell pathogenicity
Gaublomme, J. T., Yosef, N., Lee, Y., Gertner, R. S., Yang, L. V., Wu, C., Pandolfi, P. P., Mak, T., Satija, R., Shalek, A. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.009 · Cited by 575
Machado-Santos, J., Saji, E., Tröscher, A. R., Paunovic, M., Liblau, R., Gabriely, G., Bien, C. G., Bauer, J., & Lassmann, H. (2018) · Brain · doi:10.1093/brain/awy151 · Cited by 548
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial
Bar‐Or, A., Calabresi, P. A. J., Arnold, D., Markowitz, C., Shafer, S., Kasper, L. H., Waubant, E., Gazda, S., Fox, R. J., Panzara, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21363 · Cited by 527
Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease
Dominguez-Villar, M., Baecher-Allan, C. M., & Hafler, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2389 · Cited by 526
Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?
Bar‐Or, A., Fawaz, L., Fan, B., Darlington, P. J., Rieger, A., Ghorayeb, C., Calabresi, P. A., Waubant, E., Hauser, S. L., Zhang, J., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21939 · Cited by 521
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
Jelcic, I., Al Nimer, F., Wang, J., Lentsch, V., Planas, R., Jelcic, I., Madjovski, A., Ruhrmann, S., Faigle, W., Frauenknecht, K., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.011 · Cited by 508
T-bet regulates IgG class switching and pathogenic autoantibody production
Peng, S. L., Szabo, S. J., & Glimcher, L. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082114899 · Cited by 497
Th17 Cells Induce Ectopic Lymphoid Follicles in Central Nervous System Tissue Inflammation
Peters, A., Pitcher, L. A., Sullivan, J. M., Mitsdoerffer, M., Acton, S. E., Franz, B., Wucherpfennig, K., Turley, S., Carroll, M. C., Sobel, R. A., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.10.015 · Cited by 480 · cited 6×
“HLA class II expression on murine B cells was reported to be indispensable for EAE disease onset (69, 70).”
BackgroundInfluentialProinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
Li, R., Rezk, A., Miyazaki, Y., Hilgenberg, E., Touil, H., Shen, P., Moore, C. S., Michel, L., Althekair, F., Rajasekharan, S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab4176 · Cited by 453
Cayrol, R., Wosik, K., Berard, J. L., Dodelet-Devillers, A., Ifergan, I., Kebir, H., Haqqani, A. S., Kreymborg, K., Krug, S., Moumdjian, R., et al. (2008) · Nature Immunology · doi:10.1038/ni1551 · Cited by 444
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
Stern, J. N. H., Yaari, G., Vander Heiden, J. A., Church, G., Donahue, W. F., Hintzen, R. Q., Huttner, A. J., Laman, J. D., Nagra, R. M., Nylander, A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008879 · Cited by 441
Ramesh, R., Kozhaya, L., McKevitt, K., Djuretic, I. M., Carlson, T. J., Quintero, M. A., McCauley, J. L., Abreu, M. T., Unutmaz, D., & Sundrud, M. S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130301 · Cited by 440
Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
Brucklacher-Waldert, V., Stuerner, K., Kolster, M., Wolthausen, J., & Tolosa, E. (2009) · Brain · doi:10.1093/brain/awp289 · Cited by 431
CD4 CTL, a cytotoxic subset of CD4(+) T cells, their differentiation and function
Takeuchi, A., & Saito, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00194 · Cited by 431
Molnarfi, N., Schulze-Topphoff, U., Weber, M. S., Patarroyo, J. C., Prod’homme, T., Varrin-Doyer, M., Shetty, A., Linington, C., Slavin, A. J., Hidalgo, J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130699 · Cited by 418
BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis
Roychoudhuri, R., Hirahara, K., Mousavi, K., Clever, D., Klebanoff, C. A., Bonelli, M., Sciumè, G., Zare, H., Vahedi, G., Dema, B., et al. (2013) · Nature · doi:10.1038/nature12199 · Cited by 407
Tissue-resident memory T cells populate the human brain
Smolders, J., Heutinck, K. M., Fransen, N. L., Remmerswaal, E. B. M., Hombrink, P., ten Berge, I. J. M., van Lier, R. A. W., Huitinga, I., & Hamann, J. (2018) · Nature Communications · doi:10.1038/s41467-018-07053-9 · Cited by 406
Self-citationReassessing B cell contributions in multiple sclerosis
Li, R., Patterson, K. R., & Bar-Or, A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0135-x · Cited by 401
COOPERATION BETWEEN CD4+AND CD8+T CELLS: When, Where, and How
Castellino, F., & Germain, R. N. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115825 · Cited by 376
Serada, S., Fujimoto, M., Mihara, M., Koike, N., Ohsugi, Y., Nomura, S., Yoshida, H., Nishikawa, T., Terabe, F., Ohkawara, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802218105 · Cited by 349
Skulina, C., Schmidt, S., Dornmair, K., Babbe, H., Roers, A., Rajewsky, K., Wekerle, H., Hohlfeld, R., & Goebels, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308689100 · Cited by 348
Leukocyte traffic in the central nervous system: the participants and their roles
Hickey, W. F. (1999) · Seminars in Immunology · doi:10.1006/smim.1999.0168 · Cited by 345
Lünemann, J. D., Jelčić, I., Roberts, S., Lutterotti, A., Tackenberg, B., Martin, R., & Münz, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072397 · Cited by 334
Impaired early B cell tolerance in patients with rheumatoid arthritis
Samuels, J., Ng, Y.-S., Coupillaud, C., Paget, D., & Meffre, E. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042321 · Cited by 328
Patsopoulos, N. A., Barcellos, L. F., Hintzen, R. Q., Schaefer, C., van Duijn, C. M., Noble, J. A., Raj, T., IMSGC, ANZgene, Gourraud, P.-A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003926 · Cited by 312
Altered B cell signalling in autoimmunity
Rawlings, D. J., Metzler, G., Wray-Dutra, M., & Jackson, S. W. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.24 · Cited by 308
An altered immune response to Epstein-Barr virus in multiple sclerosis: A prospective study
Sundström, P., Juto, P., Wadell, G., Hallmans, G., Svenningsson, A., Nyström, L., Dillner, J., & Forsgren, L. (2004) · Neurology · doi:10.1212/01.wnl.0000130496.51156.d7 · Cited by 301
Rubtsova, K., Rubtsov, A. V., van Dyk, L. F., Kappler, J. W., & Marrack, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312348110 · Cited by 300
A High-Density Screen for Linkage in Multiple Sclerosis
(2005) · The American Journal of Human Genetics · doi:10.1086/444547 · Cited by 297
Cao, Y., Goods, B. A., Raddassi, K., Nepom, G. T., Kwok, W. W., Love, J. C., & Hafler, D. A. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8038 · Cited by 295
Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis
Rotstein, D., & Montalban, X. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0170-8 · Cited by 289
Menard, L., Saadoun, D., Isnardi, I., Ng, Y.-S., Meyers, G., Massad, C., Price, C., Abraham, C., Motaghedi, R., Buckner, J. H., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45790 · Cited by 287
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases
Pender, M. P. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.09.005 · Cited by 285
Epstein–Barr virus infection is not a characteristic feature of multiple sclerosis brain
Willis, S. N., Stadelmann, C., Rodig, S. J., Caron, T., Gattenloehner, S., Mallozzi, S. S., Roughan, J. E., Almendinger, S. E., Blewett, M. M., Brück, W., et al. (2009) · Brain · doi:10.1093/brain/awp200 · Cited by 284
B cells expressing the transcription factor T-bet drive lupus-like autoimmunity
Rubtsova, K., Rubtsov, A. V., Thurman, J. M., Mennona, J. M., Kappler, J. W., & Marrack, P. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91250 · Cited by 277
TLR9 Signaling in B Cells Determines Class Switch Recombination to IgG2a
Jegerlehner, A., Maurer, P., Bessa, J., Hinton, H. J., Kopf, M., & Bachmann, M. F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2415 · Cited by 273
B cell–derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity
Arkatkar, T., Du, S. W., Jacobs, H. M., Dam, E. M., Hou, B., Buckner, J. H., Rawlings, D. J., & Jackson, S. W. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20170580 · Cited by 267
Sørensen, T. L., Trebst, C., Kivisäkk, P., Klaege, K. L., Majmudar, A., Ravid, R., Lassmann, H., Olsen, D. B., Strieter, R. M., Ransohoff, R. M., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00097-8 · Cited by 263
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
Bar-Or, A., Pender, M. P., Khanna, R., Steinman, L., Hartung, H.-P., Maniar, T., Croze, E., Aftab, B. T., Giovannoni, G., & Joshi, M. A. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.11.003 · Cited by 262
Venken, K., Hellings, N., Broekmans, T., Hensen, K., Rummens, J.-L., & Stinissen, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6411 · Cited by 259
T cell repertoire following autologous stem cell transplantation for multiple sclerosis
Muraro, P. A., Robins, H., Malhotra, S., Howell, M., Phippard, D., Desmarais, C., de Paula Alves Sousa, A., Griffith, L. M., Lim, N., Nash, R. A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71691 · Cited by 256
Suan, D., Kräutler, N. J., Maag, J. L. V., Butt, D., Bourne, K., Hermes, J. R., Avery, D. T., Young, C., Statham, A., Elliott, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.022 · Cited by 242
CD11c-Expressing B Cells Are Located at the T Cell/B Cell Border in Spleen and Are Potent APCs
Rubtsov, A. V., Rubtsova, K., Kappler, J. W., Jacobelli, J., Friedman, R. S., & Marrack, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500055 · Cited by 238
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells
Noster, R., Riedel, R., Mashreghi, M.-F., Radbruch, H., Harms, L., Haftmann, C., Chang, H.-D., Radbruch, A., & Zielinski, C. E. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008706 · Cited by 234
Lünemann, J. D., Tintoré, M., Messmer, B., Strowig, T., Rovira, Á., Perkal, H., Caballero, E., Münz, C., Montalban, X., & Comabella, M. (2010) · Annals of Neurology · doi:10.1002/ana.21886 · Cited by 229
Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis
Lovato, L., Willis, S. N., Rodig, S. J., Caron, T., Almendinger, S. E., Howell, O. W., Reynolds, R., O’Connor, K. C., & Hafler, D. A. (2011) · Brain · doi:10.1093/brain/awq350 · Cited by 223
van Langelaar, J., van der Vuurst de Vries, R. M., Janssen, M., Wierenga-Wolf, A. F., Spilt, I. M., Siepman, T. A., Dankers, W., Verjans, G. M. G. M., de Vries, H. E., Lubberts, E., et al. (2018) · Brain · doi:10.1093/brain/awy069 · Cited by 222
Self-citationIL-10, T cell exhaustion and viral persistence
Blackburn, S. D., & Wherry, E. J. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.02.006 · Cited by 219
CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
Annibali, V., Ristori, G., Angelini, D. F., Serafini, B., Mechelli, R., Cannoni, S., Romano, S., Paolillo, A., Abderrahim, H., Diamantini, A., et al. (2011) · Brain · doi:10.1093/brain/awq354 · Cited by 213
Jackson, S. W., Jacobs, H. M., Arkatkar, T., Dam, E. M., Scharping, N. E., Kolhatkar, N. S., Hou, B., Buckner, J. H., & Rawlings, D. J. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151724 · Cited by 207
Brosnan, C. F., Cannella, B., Battistini, L., & Raine, C. S. (1995) · Neurology · doi:10.1212/wnl.45.6_suppl_6.s16 · Cited by 203
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis
Sargsyan, S. A., Shearer, A. J., Ritchie, A. M., Burgoon, M. P., Anderson, S., Hemmer, B., Stadelmann, C., Gattenlöhner, S., Owens, G. P., Gilden, D., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d865a1 · Cited by 200
Domeier, P. P., Chodisetti, S. B., Soni, C., Schell, S. L., Elias, M. J., Wong, E. B., Cooper, T. K., Kitamura, D., & Rahman, Z. S. M. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151722 · Cited by 200
Multiple sclerosis: T-cell receptor expression in distinct brain regions
Junker, A., Ivanidze, J., Malotka, J., Eiglmeier, I., Lassmann, H., Wekerle, H., Meinl, E., Hohlfeld, R., & Dornmair, K. (2007) · Brain · doi:10.1093/brain/awm214 · Cited by 189
Rahman, M. T., Ghosh, C., Hossain, M., Linfield, D., Rezaee, F., Janigro, D., Marchi, N., & van Boxel-Dezaire, A. H. H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.021 · Cited by 189
The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis
Pender, M. P. (2010) · The Neuroscientist · doi:10.1177/1073858410381531 · Cited by 186
Giunti, D., Borsellino, G., Benelli, R., Marchese, M., Capello, E., Valle, M. T., Pedemonte, E., Noonan, D., Albini, A., Bernardi, G., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1202598 · Cited by 182
GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis
Galli, E., Hartmann, F. J., Schreiner, B., Ingelfinger, F., Arvaniti, E., Diebold, M., Mrdjen, D., van der Meer, F., Krieg, C., Nimer, F. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0521-4 · Cited by 180
T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response
Knox, J. J., Buggert, M., Kardava, L., Seaton, K. E., Eller, M. A., Canaday, D. H., Robb, M. L., Ostrowski, M. A., Deeks, S. G., Slifka, M. K., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92943 · Cited by 179
Kinnunen, T., Chamberlain, N., Morbach, H., Choi, J., Kim, S., Craft, J., Mayer, L., Cancrini, C., Passerini, L., Bacchetta, R., et al. (2013) · Blood · doi:10.1182/blood-2012-09-457465 · Cited by 177
van Nierop, G. P., van Luijn, M. M., Michels, S. S., Melief, M.-J., Janssen, M., Langerak, A. W., Ouwendijk, W. J. D., Hintzen, R. Q., & Verjans, G. M. G. M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1744-4 · Cited by 174
Self-citationCutting Edge: B Cell–Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection
Barnett, B. E., Staupe, R. P., Odorizzi, P. M., Palko, O., Tomov, V. T., Mahan, A. E., Gunn, B., Chen, D., Paley, M. A., Alter, G., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1500368 · Cited by 171
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells
Hartmann, F. J., Khademi, M., Aram, J., Ammann, S., Kockum, I., Constantinescu, C., Gran, B., Piehl, F., Olsson, T., Codarri, L., et al. (2014) · Nature Communications · doi:10.1038/ncomms6056 · Cited by 166
Specific peripheral B cell tolerance defects in patients with multiple sclerosis
Kinnunen, T., Chamberlain, N., Morbach, H., Cantaert, T., Lynch, M., Preston-Hurlburt, P., Herold, K. C., Hafler, D. A., O’Connor, K. C., & Meffre, E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68775 · Cited by 164
Baranwal, M., Putzki, N., Limmroth, V., Remus, R., Lindemann, M., Knop, D., Mueller, N., Hardt, C., Kreuzfelder, E., & Grosse‐Wilde, H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.08.003 · Cited by 160
Schneider, A., Long, S. A., Cerosaletti, K. M., Ni, C., Samuels, P. L., Kita, M., & Buckner, J. H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004970 · Cited by 158
Olsson, T. P. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90135-8 · Cited by 158
Peferoen, L. A. N., Lamers, F., Lodder, L. N. R., Gerritsen, W. H., Huitinga, I., Melief, J., Giovannoni, G., Meier, U., Hintzen, R. Q., Verjans, G. M. G. M., et al. (2010) · Brain · doi:10.1093/brain/awp296 · Cited by 158
Regulatory T Cells Secreting IL-10 Dominate the Immune Response to EBV Latent Membrane Protein 1
Marshall, N. A., Vickers, M. A., & Barker, R. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6183 · Cited by 152
IL-21 and IL-21 Receptor Expression in Lymphocytes and Neurons in Multiple Sclerosis Brain
Tzartos, J. S., Craner, M. J., Friese, M. A., Jakobsen, K. B., Newcombe, J., Esiri, M. M., & Fugger, L. H. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.043 · Cited by 146
Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis
Correale, J. D., & Villa, A. (2009) · Annals of Neurology · doi:10.1002/ana.21944 · Cited by 146
Kivisäkk, P., Trebst, C., Liu, Z., Tucky, B. H., Sørensen, T. L., Rudick, R. A., Mack, M., & Ransohoff, R. M. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01947.x · Cited by 145
Defective T‐cell control of Epstein–Barr virus infection in multiple sclerosis
Pender, M. P., Csurhes, P. A., Burrows, J. M., & Burrows, S. R. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2016.87 · Cited by 145
Sørensen, P. S., Koch‐Henriksen, N., Petersen, T., Ravnborg, M. H., Oturai, A. B., & Sellebjerg, F. T. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7325-8 · Cited by 143
Flow cytometric characterization of cerebrospinal fluid cells
de Graaf, M. T., de Jongste, A. H. C., Kraan, J., et al. (2011) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20603 · Cited by 139
Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production
Cotzomi, E., Stathopoulos, P., Lee, C. S., Ritchie, A. M., Soltys, J. N., Delmotte, F. R., Oe, T., Sng, J., Jiang, R., Ma, A. K., et al. (2019) · Brain · doi:10.1093/brain/awz106 · Cited by 132
Pathogenic features of CD4+CD28– T cells in immune disorders
Broux, B., Markovic-Plese, S., Stinissen, P., & Hellings, N. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.06.003 · Cited by 131
Good‐Jacobson, K. L., Song, E., Anderson, S. M., Sharpe, A. H., & Shlomchik, M. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102885 · Cited by 130
Characteristics of differentiated CD8+ and CD4+ T cells present in the human brain
Smolders, J., Remmerswaal, E. B. M., Schuurman, K. G., Melief, J., van Eden, C. G., van Lier, R. A. W., Huitinga, I., & Hamann, J. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1155-0 · Cited by 125
Self-citationSubileau, E. A., Rezaie, P., Davies, H. A., Colyer, F. M., Greenwood, J., Male, D. K., & Romero, I. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318197eca7 · Cited by 120
RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression
zu Hörste, G. M., Wu, C., Wang, C., Cong, L., Pawlak, M., Lee, Y., Elyaman, W., Xiao, S., Regev, A., & Kuchroo, V. K. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.088 · Cited by 119
Planas, R., Santos, R. G., Ojer, P. T., Cruciani, C., Lutterotti, A., Faigle, W., Schaeren‐Wiemers, N., Espejo, C., Eixarch, H., Pinilla, C., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat4301 · Cited by 119
Harp, C. T., Ireland, S. J., Davis, L. S., Remington, G. M., Cassidy, B., Cravens, P. D., Stüve, O., Lovett‐Racke, A. E., Eagar, T. N., Greenberg, B. M., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.201040516 · Cited by 117
Dual role of ALCAM in neuroinflammation and blood–brain barrier homeostasis
Lécuyer, M., Saint‐Laurent, O., Bourbonnière, L., Larouche, S., Larochelle, C., Michel, L., Charabati, M., Abadier, M., Zandee, S., Jahromi, N. H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614336114 · Cited by 116
Induction of brain‐infiltrating T‐bet–expressing B cells in multiple sclerosis
van Langelaar, J., Rijvers, L., Janssen, M., Wierenga‐Wolf, A. F., Melief, M., Siepman, T. A. M., de Vries, H. E., Unger, P. A., van Ham, S. M., Hintzen, R. Q., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25508 · Cited by 111
Self-citationPersistence of Epstein-Barr Virus in Self-Reactive Memory B Cells
Tracy, S. I., Kakalacheva, K., Lünemann, J. D., Luzuriaga, K., Middeldorp, J. M., & Thorley‐Lawson, D. A. (2012) · Journal of Virology · doi:10.1128/jvi.01699-12 · Cited by 107
Epstein-Barr Virus: Environmental Trigger of Multiple Sclerosis?
Lünemann, J. D., Kamradt, T., Martinꝉ, R., & Münz, C. (2007) · Journal of Virology · doi:10.1128/jvi.00153-07 · Cited by 102
Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis
Correale, J. D., & Villa, A. M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.12.004 · Cited by 102
Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression
Peeters, L. M., Vanheusden, M., Somers, V. A., Wijmeersch, B. V., Stinissen, P., Broux, B., & Hellings, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01160 · Cited by 99
A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens
Sindhava, V. J., Oropallo, M. A., Moody, K. L., Naradikian, M. S., Higdon, L. E., Zhou, L., Myles, A., Green, N. M., Nündel, K., Stohl, W., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89931 · Cited by 93
Voo, K. S., Peng, G., Guo, Z., Fu, T., Li, Y., Frappier, L., & Wang, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2552 · Cited by 92
GWAS analysis implicates NF-κB-mediated induction of inflammatory T cells in multiple sclerosis
Hussman, J. P., Beecham, A. H., Schmidt, M. A., Martin, E. R., McCauley, J. L., Vance, J. M., Haines, J. L., & Pericak‐Vance, M. A. (2016) · Genes and Immunity · doi:10.1038/gene.2016.23 · Cited by 91
Bsibsi, M., Peferoen, L. A. N., Holtman, I. R., Nacken, P. J., Gerritsen, W. H., Witte, M. E., van Horssen, J., Eggen, B. J. L., van der Valk, P., Amor, S., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1317-8 · Cited by 88
Multiplexed imaging of immune cells in staged multiple sclerosis lesions by mass cytometry
Ramaglia, V., Sheikh‐Mohamed, S., Legg, K., Park, C., Rojas, O. L., Zandee, S., Fu, F., Ornatsky, O., Swanson, E. C., Pitt, D., et al. (2019) · eLife · doi:10.7554/elife.48051 · Cited by 88
Harp, C. R. P., Archambault, A. S., Sim, J. E., Ferris, S. T., Mikesell, R., Koni, P., Shimoda, M., Linington, C., Russell, J., & Wu, G. F. (2014) · Journal of Immunology · doi:10.4049/jimmunol.1402236 · Cited by 87
Baughman, E. J., Mendoza, J. P., Ortega, S. B., Ayers, C. L., Greenberg, B. M., Frohman, E. M., & Karandikar, N. J. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.12.003 · Cited by 81
Aloisi, F., Serafini, B., Magliozzi, R., Howell, O. W., & Reynolds, R. (2010) · Brain · doi:10.1093/brain/awq223 · Cited by 73
Michel, L., Grasmuck, C., Charabati, M., Lécuyer, M., Zandee, S., Dhaeze, T., Alvarez, J. I., Li, R., Larouche, S., Bourbonnière, L., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw0475 · Cited by 73
Dalpke, A., Eckerle, S., Frey, M., & Heeg, K. (2003) · European Journal of Immunology · doi:10.1002/eji.200323621 · Cited by 71
Herich, S., Schneider‐Hohendorf, T., Rohlmann, A., Ghadiri, M. K., Schulte‐Mecklenbeck, A., Zondler, L., Janoschka, C., Ostkamp, P., Richter, J., Breuer, J., et al. (2019) · Brain · doi:10.1093/brain/awz301 · Cited by 70
Piovesan, D., Tempany, J. C., Pietro, A. D., Baas, I., Yiannis, C., O’Donnell, K., Chen, Y., Peperzak, V., Belz, G. T., Mackay, C. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.060 · Cited by 69
Morandi, E., Jagessar, S. A., Hart, B. A. ‘., & Gran, B. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700178 · Cited by 66
Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells
Meckiff, B. J., Ladell, K., McLaren, J. E., Ryan, G. B., Leese, A. M., James, E. A., Price, D. A., & Long, H. M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900377 · Cited by 66
Hastings, K. T., Lackman, R. L., & Cresswell, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8569 · Cited by 61
Owens, G. P., & Bennett, J. L. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512448109 · Cited by 58
Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells
Smets, I., Fiddes, B., Garcia‐Perez, J. E., He, D., Mallants, K., Liao, W., Dooley, J., Wang, G., Humblet‐Baron, S., Dubois, B., et al. (2017) · Brain · doi:10.1093/brain/awx372 · Cited by 58
マウスおよびヒトはい中心におけるCCR6は記憶B細胞前駆体,光帯を明らかにする位置と主要な低抗原親和性【Powered by NICT】
Dan, S., Nike, J. K., Jesper, L. V. M., Danyal, B., Bourne, K., Jana, R., Tullman‐Ercek, D., Young, C., Aaron, S., Michael, E., et al. (2017) · Immunity · Cited by 57
Impact of genetic risk loci for multiple sclerosis on expression of proximal genes in patients
James, T., Lindén, M., Morikawa, H., Fernandes, S. J., Ruhrmann, S., Huss, M., Brandi, M., Piehl, F., Jagodic, M., Tegner, J. N., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy001 · Cited by 55
Lehmann‐Horn, K., Sagan, S. A., Bernard, C. C. A., Sobel, R. A., & Zamvil, S. S. (2015) · Annals of Neurology · doi:10.1002/ana.24387 · Cited by 54
Genome-wide significant association with seven novel multiple sclerosis risk loci
Lill, C. M., Luessi, F., Alcina, A., Sokolova, E. А., Ugidos-Damboriena, N., de la Hera, B., Guillot‐Noël, L., Malhotra, S., Reinthaler, E. M., Schjeide, B. M., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103442 · Cited by 48
Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients
Kreft, K. L., Verbraak, E., Wierenga‐Wolf, A. F., van Meurs, M., Oostra, B. A., Laman, J. D., & Hintzen, R. Q. (2012) · Genes and Immunity · doi:10.1038/gene.2012.34 · Cited by 46
B Cells use Conserved Polarity Cues to Regulate Their Antigen Processing and Presentation Functions
Yuseff, M.-I., & Lennon‐Duménil, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00251 · Cited by 41
GILT: Shaping the MHC Class II-Restricted Peptidome and CD4+ T Cell-Mediated Immunity
Hastings, K. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00429 · Cited by 39
Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain Lesions
Planas, R., Metz, I., Martinꝉ, R., & Sospedra, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00509 · Cited by 38
Damotte, V., Guillot‐Noël, L., Patsopoulos, N. A., Madireddy, L., Behi, M. E., Ban, M., Baranzini, S. E., Barcellos, L. F., Beecham, G. W., Beecham, A. H., et al. (2014) · Genes and Immunity · doi:10.1038/gene.2013.70 · Cited by 33
GILT expression in B cells diminishes cathepsin S steady‐state protein expression and activity
Phipps‐Yonas, H., Semik, V., & Hastings, K. T. (2012) · European Journal of Immunology · doi:10.1002/eji.201242379 · Cited by 27
Bock, L., Fraussen, J., Villar, L. M., Álvarez‐Cermeño, J. C., Wijmeersch, B. V., Pesch, V. V., Stinissen, P., & Somers, V. A. (2015) · European Journal of Neurology · doi:10.1111/ene.12925 · Cited by 14
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
The Immune Response in Multiple Sclerosis
Rodríguez Murúa, S., Farez, M. F., & Quintana, F. J. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052920-040318 · Cited by 335
Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment
Haki, M., AL-Biati, H. A., Al-Tameemi, Z. S., Ali, I. S., & Al-hussaniy, H. A. (2024) · Medicine · doi:10.1097/md.0000000000037297 · Cited by 274
Salas, L. A., Zhang, Z., Koestler, D. C., Butler, R. A., Hansen, H. M., Molinaro, A. M., Wiencke, J. K., Kelsey, K. T., & Christensen, B. C. (2022) · Nature Communications · doi:10.1038/s41467-021-27864-7 · Cited by 271
Fitzgerald, K. C., Bhargava, P., Smith, M. D., Vizthum, D., Henry-Barron, B., Kornberg, M. D., Cassard, S. D., Kapogiannis, D., Sullivan, P., Baer, D. J., et al. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104124 · Cited by 68
Selective emergence of antibody-secreting cells in the multiple sclerosis brain
Bogers, L., Engelenburg, H. J., Janssen, M., Unger, P.-P. A., Melief, M.-J., Wierenga-Wolf, A. F., Hsiao, C.-C., Mason, M. R. J., Hamann, J., van Langelaar, J., et al. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104465 · Cited by 40
Self-citation
Metadata
- Authors
- van Langelaar, J., Rijvers, L., Smolders, J., & van Luijn, M. M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-05-08
- Volume
- 11
- Pages
- 760-760
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3016526220
- Cited by
- 319
- References
- 157
- FWCI
- 23.65
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.